Privšek, N. and Grašič Kuhar, C. (2021) “Overview of the efficacy and most common side effects of treatment with cyclin-dependent kinase 4 and 6 (CDK 4/6) inhibitors in metastatic breast cancer”, Onkologija : a medical-scientific journal, 25(2), pp. 48–53. doi: 10.25670/oi2021-017on.